Literature DB >> 21377656

Tryptophan depletion and emotional processing in healthy volunteers at high risk for depression.

Adriana Feder1, Jamie Skipper, James R Blair, Katherine Buchholz, Sanjay J Mathew, Markus Schwarz, John T Doucette, Angelique Alonso, Katherine A Collins, Alexander Neumeister, Dennis S Charney.   

Abstract

BACKGROUND: Studies in depressed patients have demonstrated the presence of emotional bias toward negative stimuli, as well as dysregulated brain serotonin function. The present study compared the effects of acute tryptophan depletion (ATD) on both an emotional processing and a planning task in never-depressed healthy volunteers at high and low familial risk for depression.
METHODS: Young adults with no personal psychiatric history were stratified into two groups based on family history (n = 25). Participants were enrolled in a randomized, double-blind, placebo-controlled crossover ATD study and completed the affective go/no-go and Tower of London tasks once during each condition.
RESULTS: There was a significant treatment by valence by group interaction on the affective go/no-go, driven primarily by a greater frequency of inappropriate responses to sad than to happy distracters in the high-risk group during ATD. No group differences were observed on the Tower of London.
CONCLUSIONS: Asymptomatic individuals at high familial risk for depression showed abnormalities in emotional processing while undergoing experimentally induced tryptophan depletion. These findings support emotional processing disturbances as potential trait-level abnormalities associated with the risk of mood disorder.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377656      PMCID: PMC3941748          DOI: 10.1016/j.biopsych.2010.12.033

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  20 in total

1.  Malignancy of recurrent, early-onset major depression: a family study.

Authors:  G S Zubenko; W N Zubenko; D G Spiker; D E Giles; B B Kaplan
Journal:  Am J Med Genet       Date:  2001-12-08

2.  Comparison of the effects of amino acid mixture and placebo on plasma tryptophan to large neutral amino acid ratio.

Authors:  B E Wolfe; E D Metzger; D C Jimerson
Journal:  Life Sci       Date:  1995-03-17       Impact factor: 5.037

3.  Emotional bias and inhibitory control processes in mania and depression.

Authors:  F C Murphy; B J Sahakian; J S Rubinsztein; A Michael; R D Rogers; T W Robbins; E S Paykel
Journal:  Psychol Med       Date:  1999-11       Impact factor: 7.723

4.  Specific impairments of planning.

Authors:  T Shallice
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-06-25       Impact factor: 6.237

Review 5.  The emotional Stroop task and psychopathology.

Authors:  J M Williams; A Mathews; C MacLeod
Journal:  Psychol Bull       Date:  1996-07       Impact factor: 17.737

6.  Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder.

Authors:  Kristine Erickson; Wayne C Drevets; Luke Clark; Dara M Cannon; Earle E Bain; Carlos A Zarate; Dennis S Charney; Barbara J Sahakian
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

Review 7.  Tryptophan depletion, serotonin, and depression: where do we stand?

Authors:  Alexander Neumeister
Journal:  Psychopharmacol Bull       Date:  2003

8.  Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

Authors:  Alexander Neumeister; Allison C Nugent; Tracy Waldeck; Marilla Geraci; Markus Schwarz; Omer Bonne; Earle E Bain; David A Luckenbaugh; Peter Herscovitch; Dennis S Charney; Wayne C Drevets
Journal:  Arch Gen Psychiatry       Date:  2004-08

9.  The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers.

Authors:  F C Murphy; K A Smith; P J Cowen; T W Robbins; B J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

Review 10.  Monoamine depletion in psychiatric and healthy populations: review.

Authors:  L Booij; A J W Van der Does; W J Riedel
Journal:  Mol Psychiatry       Date:  2003-11       Impact factor: 15.992

View more
  14 in total

Review 1.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

2.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

3.  Psychological and neural mechanisms of trait mindfulness in reducing depression vulnerability.

Authors:  Natalie A Paul; Steven J Stanton; Jeffrey M Greeson; Moria J Smoski; Lihong Wang
Journal:  Soc Cogn Affect Neurosci       Date:  2012-06-19       Impact factor: 3.436

Review 4.  Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors.

Authors:  Deepika Suri; Cátia M Teixeira; Martha K Caffrey Cagliostro; Darshini Mahadevia; Mark S Ansorge
Journal:  Neuropsychopharmacology       Date:  2014-09-02       Impact factor: 7.853

5.  Association Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression.

Authors:  Francisco A Moreno; Robert P Erickson; Holly A Garriock; Joel Gelernter; Jim Mintz; Jennifer Oas-Terpstra; Marilyn A Davies; Pedro L Delgado
Journal:  Mol Neuropsychiatry       Date:  2015-09-24

6.  Monoamine polygenic liability in health and cocaine dependence: imaging genetics study of aversive processing and associations with depression symptomatology.

Authors:  Scott J Moeller; Muhammad A Parvaz; Elena Shumay; Salina Wu; Nicasia Beebe-Wang; Anna B Konova; Michail Misyrlis; Nelly Alia-Klein; Rita Z Goldstein
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

7.  Simplified dietary acute tryptophan depletion: effects of a novel amino acid mixture on the neurochemistry of C57BL/6J mice.

Authors:  Cristina L Sánchez; Amanda E D Van Swearingen; Andrew E Arrant; Caroline S Biskup; Cynthia M Kuhn; Florian D Zepf
Journal:  Food Nutr Res       Date:  2015-08-13       Impact factor: 3.894

8.  The Effects of Tryptophan on Everyday Interpersonal Encounters and Social Cognitions in Individuals with a Family History of Depression.

Authors:  Koen Hogenelst; Robert A Schoevers; Marije Aan Het Rot
Journal:  Int J Neuropsychopharmacol       Date:  2015-03-02       Impact factor: 5.176

9.  Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding.

Authors:  Karine Madsen; Eva Torstensen; Klaus K Holst; Mette E Haahr; Ulla Knorr; Vibe G Frokjaer; Malene Brandt-Larsen; Pernille Iversen; Patrick M Fisher; Gitte M Knudsen
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

Review 10.  Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis.

Authors:  Trisha A Jenkins; Jason C D Nguyen; Kate E Polglaze; Paul P Bertrand
Journal:  Nutrients       Date:  2016-01-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.